{"doi":"10.4155/fmc-2021-0317","title":"Latest Progress in the Development of Cyclooxygenase-2 Pathway Inhibitors Targeting Microsomal Prostaglandin E <sub>2</sub> Synthase-1","abstract":"Future Medicinal ChemistryVol. 14, No. 6 EditorialLatest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E2 synthase-1Krista LaBorde, Renzhong Lu & Ke-He RuanKrista LaBordeCenter for Experimental Therapeutics & Pharmacoinformatics & Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77004, USA, Renzhong Lu https://orcid.org/0000-0002-5313-5967Center for Experimental Therapeutics & Pharmacoinformatics & Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77004, USA & Ke-He Ruan *Author for correspondence: Tel.: +1 713 743 1771; E-mail Address: khruan@uh.eduhttps://orcid.org/0000-0001-7694-4452Center for Experimental Therapeutics & Pharmacoinformatics & Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77004, USAPublished Online:5 Jan 2022https://doi.org/10.4155/fmc-2021-0317AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: anti-inflammationCOX-2 inhibitorinhibitormicrosomal prostaglandin E2 synthase-1mPGES-1References1. Finetti F, Terzuoli E, Bocci E et al. Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. PLoS ONE 7(7), e40576 (2012).Crossref, Medline, CAS, Google Scholar2. Chang HH, Meuillet EJ. Identification and development of mPGES-1 inhibitors: where we are at? Future Med. Chem. 3(15), 1909–1934 (2011).Link, CAS, Google Scholar3. Ding K, Zhou Z, Hou S et al. Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs. Sci. Rep. 8(1), 5205 (2018).Crossref, Medline, Google Scholar4. Luz JG, Antonysamy S, Kuklish SL et al. Crystal structures of mPGES-1 inhibitor complexes form a basis for the rational design of potent analgesic and anti-inflammatory therapeutics. J. Med. Chem. 58(11), 4727–4737 (2015).Crossref, Medline, CAS, Google Scholar5. Sjogren T, Nord J, Ek M, Johansson P, Liu G, Geschwindner S. Crystal structure of microsomal prostaglandin E2 synthase provides insight into diversity in the MAPEG superfamily. Proc. Natl Acad. Sci. USA 110(10), 3806–3811 (2013).Crossref, Medline, Google Scholar6. Martin EM, Jones SL. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE2 in an in vitro equine inflammation model. Vet. Immunol. Immunopathol. 192, 33–40 (2017).Crossref, Medline, CAS, Google Scholar7. Maseda D, Banerjee A, Johnson EM et al. mPGES-1-mediated production of PGE2 and EP4 receptor sensing regulate T cell colonic inflammation. Front Immunol. 9, 2954 (2018).Crossref, Medline, CAS, Google Scholar8. Luo Q, Hu Q, Zheng Q et al. Enhanced mPGES-1 contributes to PD-related peritoneal fibrosis via activation of the NLRP3 inflammasome. Front Med. (Lausanne) 8, 675363 (2021).Crossref, Medline, Google Scholar9. Wang Z, Zhang S, Xiao Y et al. NLRP3 inflammasome and inflammatory diseases. Oxid. Med. Cell Longev. 2020, 4063562 (2020).Medline, Google Scholar10. Revathikumar P, Estelius J, Karmakar U et al. Microsomal prostaglandin E synthase-1 gene deletion impairs neuro-immune circuitry of the cholinergic anti-inflammatory pathway in endotoxaemic mouse spleen. PLoS ONE 13(2), e0193210 (2018).Crossref, Medline, Google Scholar11. Takemiya T, Kawakami M, Takeuchi C. Endothelial microsomal prostaglandin E synthetase-1 upregulates vascularity and endothelial interleukin-1beta in deteriorative progression of experimental autoimmune encephalomyelitis. Int. J. Mol. Sci. 19(11), 3647 (2018).Crossref, Google Scholar12. Terzuoli E, Donnini S, Finetti F et al. Linking microsomal prostaglandin E synthase-1/PGE-2 pathway with miR-15a and -186 expressio","journal":"Future Medicinal Chemistry","year":2022,"id":294894,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9625,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":980608,"name":"Renzhong Lu","orcid":"0000-0002-5313-5967","position":1,"is_corresponding":false},{"id":517667,"name":"Ke‐He Ruan","orcid":"0000-0001-7694-4452","position":2,"is_corresponding":false},{"id":980607,"name":"Krista LaBorde","orcid":"0000-0003-1110-5986","position":0,"is_corresponding":true}],"reference_count":28,"raw_metadata":null,"created_at":"2026-07-19T00:31:05.260069Z","pmid":"34985304","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}